Norio Hamamatsu;Bernhard Hubert Geierstanger;Brian R. Boettcher;Shari Lynn Caplan;Susan E. Cellitti;Douglas S. Daniels;Stuart Licht;Andreas Loew;Stephen Craig Weldon
发明人:
Brian R. Boettcher,Shari Lynn Caplan,Susan E. Cellitti,Douglas S. Daniels,Norio Hamamatsu,Bernhard Hubert Geierstanger,Stuart Licht,Andreas Loew,Stephen Craig Weldon
申请号：
US15248712
公开号：
US10669323B2
申请日:
2016.08.26
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the identification of dual function fusion proteins comprising fibroblast growth factor 21 (FGF21) and Exenatide, Exendin-4, or GLP-1. Also disclosed are methods for treating metabolic, cardiovascular, and endocrine conditions related to glucose and/or lipid homeostasis.
